Bravecto

País: União Europeia

Língua: estoniano

Origem: EMA (European Medicines Agency)

Ingredientes ativos:

fluralaner

Disponível em:

Intervet International B.V

Código ATC:

QP53BE02

DCI (Denominação Comum Internacional):

fluralaner

Grupo terapêutico:

Dogs; Cats

Área terapêutica:

Nahaparasiidi-süsteemseks kasutamiseks, Isoxazolines

Indicações terapêuticas:

Koerad:- ravi puugi ja kirbu infestatsioonid;preparaati võib kasutada osana ravi strateegia kontrolli kirbu allergia dermatiidi (FAD). - Raviks demodicosis põhjustatud Demodex canis;- ravi sarcoptic mange (Sarcoptes scabiei var. canis) nakatumise. - For reduction of the risk of infection with Babesia canis canis via transmission by Dermacentor reticulatus. [chewable tablets only]Cats:- For the treatment of tick and flea infestations;The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD). - Raviks infestatsioonid koos kõrva lestad (Otodectes cynotis).

Resumo do produto:

Revision: 17

Status de autorização:

Volitatud

Data de autorização:

2014-02-11

Folheto informativo - Bula

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Selle veterinaarravimi ajakohane teave on veterinaarravimite teabe
veebilehel.

Características técnicas

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Selle veterinaarravimi ajakohane teave on veterinaarravimite teabe
veebilehel.